viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Levothyroxine
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
L-Thyroxin
Kreeka, Saksamaa
L-Thyroxine
Prantsusmaa
Levothyroxine sodium
Kanada
Levotiroxina
Hispaania
Viited : Levothyroxine
tüüp
avaldamine
93
ajaleht
Hutchings SR, Rusho WJ, Tyler LS.
Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
Am J Health-Syst Pharm 1996 ; 53: 2185-2188.
2358
ajaleht
Das Gupta V.
Stability of levothyroxine sodium injection in polypropylene syringes.
Int J Pharm Compound 2000 ; 4, 6: 482-483.
3166
ajaleht
Strong DK, Decarie D, Ensom MHH.
Stability of Levothyroxine in Sodium Chloride for IV Administration.
Can J Hosp Pharm 2011 ; 63, 6: 437-443.
3228
ajaleht
Frenette AJ, MacLean RD, Williamson D, Marsolais P, . Donnelly RF
Stability of levothyroxine injection in glass, polyvinyl chloride, and polyolefin containers
Am J Health-Syst Pharm 2011 ;68:1723-1728.
3879
ajaleht
Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E.
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
Int J Pharm Compound 2016 ; 20, 4 : 328-332.
4465
ajaleht
Foushee A, Meredith P, Fox Laura, Wilder A.
Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
Am J Health-Syst Pharm 2020 ;77,14:1144-1148
Mentions Légales
